Search for: "CIPLA LIMITED"
Results 21 - 40
of 51
Sorted by Relevance
|
Sort by Date
5 Aug 2012, 7:34 am
It should be remembered that companies like Cipla derive almost 40% to 50% of their annual revenues from American and European markets. [read post]
25 Nov 2009, 12:00 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Ecuador to define its compulsory licence legislation (IP Watch) (Patently-O) Tavanic (Levofloxacin) – UK: Supreme Court refuses permission to appeal in Generics (UK) Ltd v Daiichi Pharmaceuticals (The SPC Blog) (JIPLP) General Nil: The value of patents in a major crisis such as an influenza pandemic – Paper by… [read post]
15 Jul 2011, 7:40 am
It is also manufactured and marketed by Cipla under trade name Tiova. [read post]
13 May 2010, 4:58 pm
(Patent Docs) Circadin (Melatonin) - UK: EWHC upholds refusal of SPC: Neurim Pharmaceuticals (1991) Limited v. [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Cipramil (Citalopram) – UK: House of Lords upholds second-generation patent that had been invalidated at first instance for insufficiency: Generics (UK) Limited and others v H Lundbeck A/S (Managing Intellectual Property)(IPKat) US: Congressman Waxman tells GPhA meeting that Hatch-Waxman model will work for follow-on biologics; draws… [read post]
22 Apr 2010, 3:51 am
Teva (Orange Book Blog) (FDA Law Blog) Levistra (Vardenafil) – US: District Court Delaware: Patent infringement complaint following ANDA filing: Bayer Schering Pharma AG et al v Teva Pharmaceuticals USA, Inc et al (Patent Docs) Nexavar (Sorafenib) – India: Bayer sues Cipla for infringement of Nexavar patent before Delhi High Court (Spicy IP) Norfloxacin – Canada: Federal Court: Judgment in s 8 proceeding: Apotex v Merck (Pharmacapsules) Prandin (Repaglinide) – US:… [read post]
2 Nov 2012, 2:38 am
However, this issue should not concern the IPAB which is limited to examining the technological proficiency of the invention: whether or not it is patentable.Pegasus offers considerable scope for the IPAB to place our patent jurisprudence on firmer legal moorings and resuscitate it from a more fanciful past." [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty) Ltd: (Afro-IP) … [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma USA… [read post]
10 Sep 2012, 10:08 pm
Cipla Ltd., 681 F.3d 1283, 1299-1301 (Fed. [read post]
8 May 2020, 11:00 am
Cipla Ltd., 681 F.3d 1283, 1294 (Fed. [read post]
18 Jul 2008, 8:34 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
5 Jul 2008, 11:05 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
16 Jan 2009, 7:00 am
(IP finance) Global - Copyright A bit about derivative works (Ip's What's Up) Australia Singapore Treaty takes effect March 2009 (Australian Trade Marks Law Blog) Capital allowances: business related costs – business transfer arrangement establishing right to intellectual property (IP Down Under) Droit de suite scheme introduced into Parliament (International Law Office) Interlocutory relief partially granted in Sebel Furniture Limited v… [read post]
16 Aug 2008, 2:43 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
25 Nov 2009, 3:00 am
(Patents4Life) R&D: the biggest spenders – discussion of 2009 EU Industrial R&D Scoreboard (IPKat) New search tool by OHIM and participating offices (Class 46) EPO – Many more changes coming next year (IPKat) EU-South Korea Free Trade Agreement: For the first time in a bilateral agreement between EU and a third country, the EU provides for the protection of European geographical indications (Class 46) Three more PGI regulations in force: Limone Interdonato Messina, Proscuitto di… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007:… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) – Lundbeck wins… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
